Guillaume Paré is Director of the Genetic and Molecular Epidemiology Laboratory (GMEL) at PHRI, Deputy Director of the Clinical Research Laboratory and Biobank (CRLB), a Senior Scientist at PHRI, a Professor of Pathology and Molecular Medicine, a Professor, Health Research Methods, Evidence and Impact, and a University Scholar at McMaster University.
He holds the Cisco Professorship in Integrated Health Systems. His clinical interests are centered on lipoprotein disorders, obesity and cardiovascular disease prevention, with research interests in cardiovascular genetics, biomarker development and pharmacogenomics. Dr. Paré’s research combines high-throughput biomarker screens with genetics, bioinformatics and epidemiology to identify novel cardio-metabolic biomarkers. He has published more than 200 papers and has been cited over 27,000 times.
A medical biochemist with board certification from the Royal College of Physicians and Surgeons of Canada, Guillaume Paré completed a Master’s in Human Genetics at McGill University under the supervision of renowned geneticist Dr. Thomas Hudson. He further trained in genetic epidemiology with Dr. Paul Ridker at Harvard Medical School.